EXC
53
3
NVDA
57
-2
PSA
37
2
CRM
59
-11
VIX
19
-2
DVN
40
-2
DIS
72
2
GIS
54
2
HPE
68
-5
BK
77
2
PNW
57
2
NEE
52
2
LH
48
2
ROK
47
-3
FSLR
60
-10
TSN
47
3
AIV
48
4
C
85
3
VNO
52
2
ROST
70
2
EXC
53
3
NVDA
57
-2
PSA
37
2
CRM
59
-11
VIX
19
-2
DVN
40
-2
DIS
72
2
GIS
54
2
HPE
68
-5
BK
77
2
PNW
57
2
NEE
52
2
LH
48
2
ROK
47
-3
FSLR
60
-10
TSN
47
3
AIV
48
4
C
85
3
VNO
52
2
ROST
70
2
Financhill
Back

Apollo Global Management, Inc. Vs. CRISPR Therapeutics AG Industry Stock Comparison

Buy
54

APO
Apollo Global Management, Inc.

Last Price:
$148.82
Seasonality Move:
1.93%
Sell
49

CRSP
CRISPR Therapeutics AG

Last Price:
$56.78
Seasonality Move:
9.38%
Buy
54
Apollo Global Management, Inc. (APO) is a Buy

Is Apollo Global Management, Inc. a Buy, Sell or Hold?

  • The current Apollo Global Management, Inc. [APO] share price is $148.85. The Score for APO is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • APO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $56.71. The Score for CRSP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APO Stock Price Chart

What is Apollo Global Management, Inc.'s stock price today?

  • The Apollo Global Management, Inc. share price today is $148.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APO is experiencing slight buying pressure.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $56.71
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.

APO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.67 Buy
Relative Strength Index (14 RSI): 69.36 Buy
Chaikin Money Flow: 383751 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (131.3 - 147.7) Buy
Bollinger Bands (100): (126.55 - 142.29) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 51.37 Buy
Chaikin Money Flow: 559526 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.25 - 57.53) Buy
Bollinger Bands (100): (52.44 - 65.38) Sell

APO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 147.39 Buy
20-day SMA: 142.14 Buy
50-day SMA: 133.23 Buy
200-day SMA: 135.8 Buy
8-day EMA: 147.24 Buy
20-day EMA: 142.93 Buy
50-day EMA: 137.37 Buy
200-day EMA: 136.52 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.09 Buy
20-day SMA: 55.85 Buy
50-day SMA: 58.16 Sell
200-day SMA: 51.3 Buy
8-day EMA: 56.4 Buy
20-day EMA: 56.1 Buy
50-day EMA: 56.43 Buy
200-day EMA: 38.14 Buy

Apollo Global Management, Inc. Earnings Growth & APO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $1.27 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

Apollo Global Management, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):